In contrast, the ureido-substituted sulfonamides 4 and 5 were members of a congeneric series in which many CA IX/XII selective inhibitors were discovered [51,52], and their selectivity for the tumor-associated vs. the cytosolic isoforms was explained by detailed X-ray crystallographic data [70,71]. This evidence concerns the gene CA9 and neoplasm.